These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11274995)

  • 1. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
    Nazarian A; Krall CM; Osburn JR; McDougall SA
    Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasonic vocalization production of preweanling rats: effects of central and peripheral administration of alpha2-adrenoceptor agonists.
    Krall CM; Andicochea CT; McDougall SA
    Eur J Pharmacol; 2005 Jul; 517(3):200-7. PubMed ID: 15985263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. kappa-Opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.
    Collins RL; Zavala AR; Nazarian A; McDougall SA
    Brain Res Dev Brain Res; 2000 Jan; 119(1):97-103. PubMed ID: 10648876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
    Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM
    Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opioid mediated locomotor activity in the preweanling rat: role of pre- and postsynaptic dopamine receptors.
    McDougall SA; Garmsen GM; Meier TL; Crawford CA
    Psychopharmacology (Berl); 1997 Sep; 133(1):62-8. PubMed ID: 9335082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
    Cui CL; Wu LZ; Han JS
    Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
    Aley KO; Levine JD
    J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
    Morrone LA; Romanelli L; Amico MC; Valeri P
    Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid-mediated behavioral sensitization in the preweanling rat: relationship to Fos immunoreactivity.
    Collins RL; Zavala AR; Ingersoll VY; Duke MA; Crawford CA; McDougall SA
    Psychopharmacology (Berl); 1998 Jun; 137(3):282-91. PubMed ID: 9683006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
    Hill MP; Brotchie JM
    Br J Pharmacol; 1999 Dec; 128(7):1577-85. PubMed ID: 10602339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
    Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments.
    Ware TD; Paul D
    Eur J Pharmacol; 2000 Feb; 389(2-3):181-5. PubMed ID: 10688982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
    Raffa RB; Baron DA; Tallarida RJ
    Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat.
    Shan D; Wang H; Su Y; Jing Y; Wong TM
    Eur J Pharmacol; 2007 Jan; 555(2-3):100-5. PubMed ID: 17126321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive actions of dexmedetomidine and the kappa-opioid agonist U-50,488H against noxious thermal, mechanical and inflammatory stimuli.
    Idänpään-Heikkilä JJ; Kalso EA; Seppälä T
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1306-13. PubMed ID: 7996439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
    Jewett DC; Grace MK; Jones RM; Billington CJ; Portoghese PS; Levine AS
    Brain Res; 2001 Aug; 909(1-2):75-80. PubMed ID: 11478923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.